CoChat

Glucocorticoids induce senescence in primary human tenocytes by inhibition of sirtuin 1 and activation of the p53/p21 pathway: in vivo and in vitro evidence

Open access
Poulsen, Raewyn C, Watts, Anna C, Murphy, Richard J, Snelling, Sarah J, Carr, Andrew J, Hulley, Philippa A · 2014 · Annals of the Rheumatic Diseases
Cited by 123

The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.

Abstract

UNLABELLED: Cellular senescence is an irreversible side effect of some pharmaceuticals which can contribute to tissue degeneration. OBJECTIVE: To determine whether pharmaceutical glucocorticoids induce senescence in tenocytes. METHODS: Features of senescence (β-galactosidase activity at pH 6 (SA-β-gal) and active mammalian/mechanistic target of rapamycin (mTOR) in cell cycle arrest) as well as the activity of the two main pathways leading to cell senescence were examined in glucocorticoid-treated primary human tenocytes. Evidence of senescence-inducing pathway induction in vivo was obtained using immunohistochemistry on tendon biopsy specimens taken before and 7 weeks after subacromial Depo-Medrone injection. RESULTS: Dexamethasone treatment of tenocytes resulted in an increased percentage of SA-βgal-positive cells. Levels of phosphorylated p70S6K did not decrease with glucocorticoid treatment indicating mTOR remained active. Increased levels of acetylated p53 as well as increased RNA levels of its pro-senescence effector p21 were evident in dexamethasone-treated tenocytes. Levels of the p53 deacetylase sirtuin 1 were lower in dexamethasone-treated cells compared with controls. Knockdown of p53 or inhibition of p53 activity prevented dexamethasone-induced senescence. Activation of sirtuin 1 either by exogenous overexpression or by treatment with resveratrol or low glucose prevented dexamethasone-induced senescence. Immunohistochemical analysis of tendon biopsies taken before and after glucocorticoid injection revealed a significant increase in the percentage of p53-positive cells (p=0.03). The percentage of p21-positive cells also tended to be higher post-injection (p=0.06) suggesting glucocorticoids activate the p53/p21 senescence-inducing pathway in vivo as well as in vitro. CONCLUSION: As cell senescence is irreversible in vivo, glucocorticoid-induced senescence may result in long-term degenerative changes in tendon tissue.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1136/annrheumdis-2012-203146

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 7 references

Research works printed but not linked: 36

  1. Garbe, 1997, Inhaled and nasal glucocorticoids and the risks of ocular hypertension or open-angle glaucoma, JAMA, 277, 722, 10.1001/jama.1997.03540330044033 · DOI · Paper page
  2. Oikarinen, 1991, New aspects of the mechanism of corticosteroid-induced dermal atrophy, Clin Exper Dermatol, 16, 416, 10.1111/j.1365-2230.1991.tb01225.x · DOI
  3. Butler, 1991, Bone-mineral content in patients with rheumatoid-arthritis—relationship to low-dose steroid-therapy, Br J Rheumatol, 30, 86, 10.1093/rheumatology/30.2.86 · DOI
  4. Ford, 1979, Tendon-rupture after local steroid injection, South Med J, 72, 827, 10.1097/00007611-197907000-00019 · doi:10.1097/00007611-197907000-00019
  5. Nichols, 2005, Complications associated with the use of corticosteroids in the treatment of athletic injuries, Clin J Sport Med, 15, 370, 10.1097/01.jsm.0000179233.17885.18 · DOI · Paper page
  6. Scutt, 2006, Glucocorticoids inhibit tenocyte proliferation and Tendon progenitor cell recruitment, J Orthop Res, 24, 173, 10.1002/jor.20030 · DOI
  7. Wong, 2009, The effect of glucocorticoids on tendon cell viability in human tendon explants, Acta Orthop, 80, 363, 10.3109/17453670902988386 · DOI
  8. Torricelli, 2006, Effects of systemic glucocorticoid administration on tenocytes, Biomed Pharmacother, 60, 380, 10.1016/j.biopha.2006.07.003 · DOI
  9. Poulsen, 2011, Protection against glucocorticoid-induced damage in human tenocytes by modulation of ERK, Akt and forkhead signalling, Endocrinology, 152, 503, 10.1210/en.2010-1087 · DOI
  10. Millis, 1992, Differential expression of metalloproteinase and tissue inhibitor of metalloproteinase genes in aged human fibroblasts, Exp Cell Res, 201, 373, 10.1016/0014-4827(92)90286-H · DOI · Paper page
  11. Abate, 2009, Pathogenesis of tendinopathies: inflammation or degeneration, Arthritis Res Ther, 11, 235, 10.1186/ar2723 · DOI · Paper page
  12. Millar, 2009, Cytokines and apoptosis in supraspinatus tendinopathy, Journal of Bone and Joint Surgery-British Volume, 91B, 417
  13. Demidenko, 2008, Growth stimulation leads to cellular senescence when the cell cycle is blocked, Cell Cycle, 7, 3355, 10.4161/cc.7.21.6919 · DOI · Paper page
  14. Park, 2002, Regulation of ribosomal S6 kinase 2 by mammalian target of rapamycin, J Biol Chem, 277, 31423, 10.1074/jbc.M204080200 · DOI
  15. Kubica, 2008, Activation of the mammalian target of rapamycin complex 1 is both necessary and sufficient to stimulate eukaryotic initiation factor 2Bvarepsilon mRNA translation and protein synthesis, Int J Biochem Cell Biol, 40, 2522, 10.1016/j.biocel.2008.04.010 · DOI
  16. Kubica, 2005, Resistance exercise increases muscle protein synthesis and translation of eukaryotic initiation factor 2Bepsilon mRNA in a mammalian target of rapamycin-dependent manner, J Biol Chem, 280, 7570, 10.1074/jbc.M413732200 · DOI · Paper page
  17. Blagosklonny, 2006, Cell senescence: hypertrophic arrest beyond the restriction point, J Cell Physiol, 209, 592, 10.1002/jcp.20750 · DOI
  18. Dimri, 1995, A biomarker that identifies senescent human cells in culture and in aging skin in vivo, Proc Nat Acad Sci, 92, 9363, 10.1073/pnas.92.20.9363 · DOI · Paper page
  19. Kessel, 1977, The painful arc syndrome. Clinical classification as a guide to management, J Bone Joint Surg, 59, 166, 10.1302/0301-620X.59B2.873977 · doi:10.1302/0301-620x.59b2.873977
  20. Hawkins, 1980, Impingement syndrome in athletes, Am J Sports Med, 8, 151, 10.1177/036354658000800302 · DOI · Paper page
  21. Jobe, 1982, Delineation of diagnostic criteria and a rehabilitation program for rotator cuff injuries, Am J Sports Med, 10, 336, 10.1177/036354658201000602 · DOI · Paper page
  22. Cook, 2004, Abnormal tenocyte morphology is more prevalent than collagen disruption in asymptomatic athletes' patellar tendons, J Orthop Res, 22, 334, 10.1016/j.orthres.2003.08.005 · DOI · Paper page
  23. Muller, 2009, Cellular Senescence: Molecular Mechanisms, In Vivo Significance, and Redox Considerations, Antioxid Redox Signal, 11, 59, 10.1089/ars.2008.2104 · DOI · Paper page
  24. Langley, 2002, Human SIR2 deacetylates p53 and antagonises PML/p53-induced cellular senescence, Embo J, 21, 2383, 10.1093/emboj/21.10.2383 · DOI · Paper page
  25. Crochemore, 2002, Enhancement of p53 activity and inhibition of neural cell proliferation by glucocorticoid receptor activation, FASEB J, 16, 10.1096/fj.01-0577com · DOI
  26. Knights, 2006, Distinct p53 acetylation cassettes differentially influence gene-expression patterns and cell fate, J Cell Biol, 173, 533, 10.1083/jcb.200512059 · DOI · Paper page
  27. Fang, 1999, p21Waf1/Cip1/Sdi1 induces permanent growth arrest with markers of replicative senescence in human tumor cells lacking functional p53, Oncogene, 18, 2789, 10.1038/sj.onc.1202615 · DOI · Paper page
  28. Cha, 1998, Glucocorticoids Stimulate p21 Gene Expression by Targeting Multiple Transcriptional Elements within a Steroid Responsive Region of the p21waf1/cip1 Promoter in Rat Hepatoma Cells, J Biol Chem, 273, 1998, 10.1074/jbc.273.4.1998 · DOI
  29. Luo, 2001, Negative control of p53 by Sir2 alpha promotes cell survival under stress, Cell, 107, 137, 10.1016/S0092-8674(01)00524-4 · DOI · Paper page
  30. Vaziri, 2001, hSIR2(SIRT1) functions as an NAD-dependent p53 deacetylase, Cell, 107, 149, 10.1016/S0092-8674(01)00527-X · DOI · Paper page
  31. Ota, 2007, Sirt1 modulates premature senescence-like phenotype in human endothelial cells, Journal of Molecular and Cellular Cardiology, 43, 571, 10.1016/j.yjmcc.2007.08.008 · DOI · Paper page
  32. Ota, 2005, Inhibition of Sirt1, a human homolog of yeast longevity gene, Sir2, induces senescence-like phenotype in human endothelial cells, Circulation, 112, 351
  33. Nemoto, 2004, Nutrient availability regulates SIRT1 through a forkhead-dependent pathway, Science, 306, 2105, 10.1126/science.1101731 · DOI · Paper page
  34. Wang, 2011, Protective effects of resveratrol through the up-regulation of SIRT1 expression in the mutant hSOD1-G93A-bearing motor neuron-like cell culture model of amyotrophic lateral sclerosis, Neurosci Lett, 503, 250, 10.1016/j.neulet.2011.08.047 · DOI
  35. Heathfield, 2008, Caveolin-1 expression and stress-induced premature senescence in human invertebral disc degeneration, Arthritis Res Ther, 10, 10.1186/ar2468 · DOI
  36. Koziowski, 2012, RPE cell senescence: A key contributor to age-related macular degeneration, Med Hypotheses, 78, 505, 10.1016/j.mehy.2012.01.018 · DOI

Cited by

See all 123

Metadata

Authors
Poulsen, R. C., Watts, A. C., Murphy, R. J., Snelling, S. J., Carr, A. J., & Hulley, P. A.
Venue
Annals of the Rheumatic Diseases
Publisher
Elsevier BV
Published
2014-07
Volume
73
Issue
7
Pages
1405-1413
ISSN
0003-4967 (ISSN-L)
OpenAlex
W2125855766
Cited by
123
References
7
FWCI
4.90
Type
journal article
Language
en
Open access
hybrid
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Glucocorticoids induce senescence in primary human tenocytes by inhibition of sirtuin 1 and activation of the p53/p21 pathway: in vivo and in vitro evidence. https://app.cochat.ai/papers/10.1136/annrheumdis-2012-203146
The paper
Poulsen, R. C., Watts, A. C., Murphy, R. J., Snelling, S. J., Carr, A. J., & Hulley, P. A. (2014). Glucocorticoids induce senescence in primary human tenocytes by inhibition of sirtuin 1 and activation of the p53/p21 pathway: in vivo and in vitro evidence. Annals of the Rheumatic Diseases. https://doi.org/10.1136/annrheumdis-2012-203146

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.